Finoriq research workspace
IDEXX LABORATORIES INC /DE (IDXX) SEC Filings & Filing Highlights
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion. Review IDXX SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
- Company
- IDEXX LABORATORIES INC /DE (IDXX)
- Ticker
- IDXX
- Market Cap
- $44.6B
- Latest Price
- $565.15
- Industry
- Diagnostics
IDEXX LABORATORIES INC /DE (IDXX) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for IDEXX LABORATORIES INC /DE (IDXX).
| Event | Form | Date |
|---|---|---|
| The voting results at the Annual Meeting with respect to each of the matters described above, w...On May 12, 2026, the Corporation held its Annual Meeting. At the Annual Meeting, shareholders considered and voted on the following proposa... | 8-K5.07 | 2026-05-15 |
| Amendments to Articles of Incorporation or ByLaws; Change in Fiscal YearAmendments to Articles of Incorporation or ByLaws; Change in Fiscal Year | 8-K5.03 | 2026-05-15 |
| IDEXX Laboratories Announces First Quarter ResultsIDEXX Laboratories Announces First Quarter Results | 8-K2.02 | 2026-05-05 |
| On March 24, 2026, IDEXX Laboratories, Inc. (“IDEXX”) and Nimrata Hunt, PhD, Executive Vice Pre...On March 24, 2026, IDEXX Laboratories, Inc. (“IDEXX”) and Nimrata Hunt, PhD, Executive Vice President, Global Strategy and Commercial, mutu... | 8-K5.02 | 2026-03-26 |
| (b) On February 13, 2026, Ms. M. Anne Szostak provided IDEXX Laboratories, Inc. (the “Company”)...(b) On February 13, 2026, Ms. M. Anne Szostak provided IDEXX Laboratories, Inc. (the “Company”) notice of her intention to retire from the... | 8-K5.02 | 2026-02-13 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.